Literature DB >> 7073761

Prednisolone binding to albumin and transcortin in the presence of cortisol.

M L Rocci, R D'Ambrosio, N F Johnson, W J Jusko.   

Abstract

The protein binding of prednisolone was assessed in a 5% albumin solution and in pooled human serum, alone and in the presence of various amounts of cortisol. Significant displacement of prednisolone from transcortin binding sites occurred with little or no change in transcortin binding capacity or affinity constant for prednisolone, suggesting competitive inhibition of prednisolone binding by cortisol. Little or no displacement of prednisolone from the protein binding sites on albumin occurred though a decrease in the number of binding sites (four vs two), and an increase in the affinity constant for the albumin-prednisolone interaction (4.32 X 10(2) vs 9.43 X 10(2) M-1) occurred in the presence of cortisol. Allosteric conformational changes may occur in albumin structure in the presence of cortisol. These alterations have no effect on the fraction of prednisolone bound to albumin.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7073761     DOI: 10.1016/0006-2952(82)90172-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  17 in total

1.  Indirect pharmacodynamic models for responses with multicompartmental distribution or polyexponential disposition.

Authors:  W Krzyzanski; W J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-02       Impact factor: 2.745

2.  Pharmacokinetics of total and unbound prednisone and prednisolone in stable kidney transplant recipients with diabetes mellitus.

Authors:  Ileana A Ionita; Ken Ogasawara; Reginald Y Gohh; Fatemeh Akhlaghi
Journal:  Ther Drug Monit       Date:  2014-08       Impact factor: 3.681

Review 3.  Clinical pharmacokinetics of prednisone and prednisolone.

Authors:  B M Frey; F J Frey
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

4.  Tetra- and Penta-Cyclic Triterpenes Interaction with Lipid Bilayer Membrane: A Structural Comparative Study.

Authors:  Rola Abboud; Catherine Charcosset; Hélène Greige-Gerges
Journal:  J Membr Biol       Date:  2016-01-13       Impact factor: 1.843

Review 5.  Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids.

Authors:  Vivaswath S Ayyar; William J Jusko
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

6.  Comparative study of availability of prednisolone after intestinal infusion of prednisolone metasulfobenzoate and prednisone.

Authors:  C Rollin; O Chosidow; B Diquet; C Dutreuil; S Herson; J Revuz; J C Delchier
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

7.  Prednisolone pharmacokinetics and pharmacodynamics in relation to sex and race.

Authors:  M H Magee; R A Blum; C D Lates; W J Jusko
Journal:  J Clin Pharmacol       Date:  2001-11       Impact factor: 3.126

8.  Prednisolone protein binding in renal transplant patients.

Authors:  P A Reece; A P Disney; I Stafford; J C Shastry
Journal:  Br J Clin Pharmacol       Date:  1985-08       Impact factor: 4.335

9.  Effect of inflammatory bowel disease on absorption and disposition of prednisolone.

Authors:  R L Milsap; D E George; S J Szefler; K A Murray; E Lebenthal; W J Jusko
Journal:  Dig Dis Sci       Date:  1983-02       Impact factor: 3.199

10.  The macromolecular binding of prednisone in plasma of healthy volunteers including pregnant women and oral contraceptive users.

Authors:  L E Gustavson; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1985-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.